Pro-active Genetic Testing in Kidney Transplant Patients

Mayo Clinic

Status: Active, not recruiting

Conditions: Kidney Transplant

Treatments: Diagnostic Test: Genetic Health Screen Panel

Study type: Observational

Funder types: Other

Identifiers

NCT05298904

21-009697

NCI-2022-02382 (Other Grant/Funding Number)

Details and patient eligibility

About

The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.

Enrollment: 177 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

- Post transplant Kidney and Kidney Pancreas recipients.

Exclusion criteria

• Simultaneous Liver Kidney Transplant.
• Simultaneous Heart Kidney Transplant.
• Non renal transplant history.

Trial design

177 participants in 1 patient group

Kidney Transplants

Description:

Kidney transplant patients who are within one-year post transplant.

Treatment:

Diagnostic Test: Genetic Health Screen Panel